NY A08345 | 2023-2024 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on December 13 2023 - 25% progression
Action: 2024-01-18 - print number 8345a
Pending: Assembly Health Committee
Text: Latest bill text (Amended) [HTML]

Summary

Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.

Sponsors


History

DateChamberAction
2024-01-18Assemblyprint number 8345a
2024-01-18Assemblyamend and recommit to health
2024-01-03Assemblyreferred to health
2023-12-13Assemblyreferred to health

Same As/Similar To

S04786 (Same As) 2024-01-30 - referred to health

New York State Sources


Bill Comments

feedback